Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma

Lori A Leslie, MD, Lori A. Leslie, MD, Tatyana A Feldman, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Scott D. Rowley, MD FACP, Andrew L. Pecora, MD, Andre Goy, MD, Michele L. Donato, MD

Blood (2016) 128 (22): 5843.

https://doi.org/10.1182/blood.V128.22.5843.5843

Published: 2016

Journal Articles

High Dose Telmisartan for Prevention of Acute Graft Vs. Host Disease

David H. Schwartz, MD/ PhD, Sujatha Iyengar, PhD, Michele L Donato, MD FACP, Alan P Skarbnik, MD, David H. Vesole, MD, Scott D. Rowley, MD FACP, Themba L Nyirenda, PhD

Blood (2016) 128 (22): 5783.

https://doi.org/10.1182/blood.V128.22.5783.5783

Published: 2016

Journal Articles

Radius: A Phase 2, Randomized Trial of Standard of Care (SOC) with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients (pts) with FLT3 -Itd-Mutated Acute Myeloid Leukemia (AML)

Richard T. Maziarz, MD, Mrinal M Patnaik, MBBS, Bart L. Scott, MD, Sanjay R. Mohan, MD, Abhinav Deol, MD, Scott D. Rowley, MD FACP, Dennis Dong Hwan Kim, MD PhD, Kelly Haines, BS, Gaetano Bonifacio, MD, Patrice Rine, Hugo F. Fernandez, MD

Blood (2016) 128 (22): 2248.

https://doi.org/10.1182/blood.V128.22.2248.2248

Published: 2016

Journal Articles

Outcomes of Salvage Stem Cell Transplantation in Hodgkin Lymphoma in a Single Institution in the Modern Era

Tatyana Feldman, MD, Larysa Sanchez, MD, Lina Starovoitova, BS, Ewelina Protomastro, MS, Yucai Wang, MD PhD, Neil Shah, MD, Michele L. Donato, MD, Scott D. Rowley, MD FACP, David H. Vesole, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Andre Goy, MD MS

Blood (2015) 126 (23): 5500.

https://doi.org/10.1182/blood.V126.23.5500.5500

Published: 2015

Journal Articles

High Rate of Engraftment Syndrome in Elderly Patients with Multiple Myeloma Receiving Autologous Peripheral Blood Stem Cell Transplantation

Phyllis McKiernan, APN, MSN, OCN, David Siegel, MD PhD, David H. Vesole, MD, Themba Nyirenda, PhD, Scott D. Rowley, MD FACP, Alan P Skarbnik, MD, Ann Ferolin-Ocot, RN, BSN, OCN, Daniel Kim, Neil Shah, MD, Michele L. Donato, MD

Blood (2015) 126 (23): 3175.

https://doi.org/10.1182/blood.V126.23.3175.3175

Published: 2015

Journal Articles

Haploidentical Allogeneic Transplantation Provides Comparable Outcomes to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological Malignancies

Melissa F Baker, APN, Daniel Kim, Michele L Donato, MD FACP, Andrew L Pecora, MD FACP, David H. Vesole, MD PhD, Alan P Skarbnik, MD, Barbara Adler-Brecher, Michele Boonstra, APN, Brenda Diaz, APN, Phyllis McKiernan, APN, Pamela Sutherland, APN, Scott D Rowley, MD FACP

Blood (2014) 124 (21): 1226.

https://doi.org/10.1182/blood.V124.21.1226.1226

Published: 2014

Journal Articles

Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple Myeloma

Phyllis McKiernan, APN, MSN, David H. Vesole, MD PhD, David S. Siegel, MD PhD, Scott D Rowley, MD FACP, Melissa F Baker, APN, Brenda Diaz, APN, Themba Nyirenda, PhD, Joshua R. Richter, MD, Pamela Sutherland, APN, Michele L. Donato, MD

Blood (2014) 124 (21): 5918.

https://doi.org/10.1182/blood.V124.21.5918.5918

Published: 2014

Journal Articles

Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

George Nahas, DO, Arpita P Gandhi, MD, Michele L. Donato, MD, Themba Nyirenda, PhD, David H. Vesole, MD, PhD, Andrew L Pecora, Stuart Goldberg, MD, Andre Goy, MD, Tatyana Feldman, MD, Anthony R. Mato, MD, Pritish K. Bhattacharyya, MD, Melissa Baker, APN, Phyllis McKiernan, APN, Brenda Diaz, APN, Scott D Rowley, MD, FACP

Blood (2013) 122 (21): 4545.

https://doi.org/10.1182/blood.V122.21.4545.4545

Published: 2013

Journal Articles

Combination Melphalan and Bortezomib Conditioning with Autologous Hematopoietic Stem Cell Support in Patients with Advanced Multiple Myeloma. A Phase I/II Study.

Scott D. Rowley, MD, FACP, David Siegel, MD, PhD, Michele L. Donato, MD, Andrew L. Pecora, MD, Tatyana Feldman, MD, Stuart Goldberg, MD, Andre Goy, MD, Aisha Masood, MD

Blood (2009) 114 (22): 1214.

https://doi.org/10.1182/blood.V114.22.1214.1214

Published: 2009

Journal Articles

Outcome of Patients with Myeloproliferative Disorders Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Michele L. Donato, MD, Angela Prann, MPH, Anna Ullrich, RN, Tatyana Feldman, MD, Stuart L. Goldberg, Andre Goy, MD, Aisha Masood, MD, Andrew L. Pecora, MD, David S. Siegel, Scott D. Rowley, MD, FACP

Blood (2008) 112 (11): 2797.

https://doi.org/10.1182/blood.V112.11.2797.2797

Published: 2008

Journal Articles

Autologous Peripheral Blood Stem Cell Transplant for Relapsed or Refractory T-Cell Non-Hodgkin’s Lymphoma Results in Inferior Long Term Survival when Compared to Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphomas.

Jack W. Hsu, MD, Priya Singh, MD, Stuart L. Goldberg, MD, Andrew L. Pecora, MD, David S. Siegel, MD, PhD, Scott D. Rowley, MD, FACP

Blood (2004) 104 (11): 5241.

https://doi.org/10.1182/blood.V104.11.5241.5241

Published: 2004

Journal Articles

A Myeloablative Conditioning Regimen Is Required to Produce Durable Engraftment and Immune Reconsitution in Related and Unrelated Multi-Antigen HLA Mismatched Pan-T-Cell Depleted Limited T-Cell Add-Back Transplants.

Jack W. Hsu, MD, Scott D. Rowley, MD, FACP, Stuart L. Goldberg, MD, David S. Siegel, MD, PhD, Robert A. Preti, PhD, Andrew L. Pecora, MD

Blood (2004) 104 (11): 5185.

https://doi.org/10.1182/blood.V104.11.5185.5185

Published: 2004

NARROW

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma

High Dose Telmisartan for Prevention of Acute Graft Vs. Host Disease

Radius: A Phase 2, Randomized Trial of Standard of Care (SOC) with or without Midostaurin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients (pts) with FLT3 -Itd-Mutated Acute Myeloid Leukemia (AML)

Outcomes of Salvage Stem Cell Transplantation in Hodgkin Lymphoma in a Single Institution in the Modern Era

High Rate of Engraftment Syndrome in Elderly Patients with Multiple Myeloma Receiving Autologous Peripheral Blood Stem Cell Transplantation

Haploidentical Allogeneic Transplantation Provides Comparable Outcomes to HLA-Matched or Mismatched Unrelated Donor Grafts in Hematological Malignancies

Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple Myeloma

Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)

Combination Melphalan and Bortezomib Conditioning with Autologous Hematopoietic Stem Cell Support in Patients with Advanced Multiple Myeloma. A Phase I/II Study.

Outcome of Patients with Myeloproliferative Disorders Treated with Allogeneic Hematopoietic Stem Cell Transplantation

Autologous Peripheral Blood Stem Cell Transplant for Relapsed or Refractory T-Cell Non-Hodgkin’s Lymphoma Results in Inferior Long Term Survival when Compared to Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphomas.

A Myeloablative Conditioning Regimen Is Required to Produce Durable Engraftment and Immune Reconsitution in Related and Unrelated Multi-Antigen HLA Mismatched Pan-T-Cell Depleted Limited T-Cell Add-Back Transplants.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only